Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ:001540)
South Korea · Delayed Price · Currency is KRW 7,990.00
0.00 (0.00%)
At close: Mar 27, 2026
Ahn-Gook Pharmaceutical Revenue
In the year 2025, Ahn-Gook Pharmaceutical had annual revenue of 306.87B KRW with 13.19% growth. Ahn-Gook Pharmaceutical had revenue of 76.61B in the quarter ending December 31, 2025, with 8.37% growth.
Revenue
306.87B
Revenue Growth
+13.19%
P/S Ratio
0.30
Revenue / Employee
784.84M
Employees
391
Market Cap
90.81B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 306.87B | 35.76B | 13.19% |
| Dec 31, 2024 | 271.12B | 37.44B | 16.02% |
| Dec 31, 2023 | 233.68B | 28.29B | 13.77% |
| Dec 31, 2022 | 205.39B | 41.85B | 25.59% |
| Dec 31, 2021 | 163.53B | 20.17B | 14.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cosmax Nbt | 287.48B |
| H.PIO | 257.56B |
| Daehan Nupharm | 202.40B |
| Sinsin Pharmaceutical | 113.78B |
| Hwail Pharmaceutical | 107.87B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 106.44B |
| Sam-A Pharm. | 76.66B |
| Polaris AI Pharma | 63.94B |